Fig. 6A displays the top 20 gene with the highest mutation frequency in the TCGA-PRAD cohort, with significant differences in the mutation rates of TP53, FOXA1, CACNA1E, and SPTA1 between the two groups. This evidence concerns the gene SPTA1 and prostate adenocarcinoma.